Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
HIV and TB in Practice for nurses: Starting ART for treatment and prevention in people with active TB and HIV

This article provides information for nurses on starting HIV treatment for people with HIV and active TB.

Published
29 November 2012
From
HIV & AIDS treatment in practice
Treatment Action Group welcomes FDA review of first new tuberculosis drug in half a century

“The decision you make today is going to affect millions of people around the world,” TAG executive director Mark Harrington said today to the FDA Center for Drug Evaluation and Research at the landmark Anti-Infective Drugs Advisory Committee Meeting.

Published
29 November 2012
From
Treatment Action Group
New type of TB drug deemed safe by FDA

A tuberculosis drug under review by the FDA seems to work well in combination with other treatments while appearing to be "safe and well-tolerated," the agency said. Bedaquiline (Sirturo) could provide help in treating multi-drug resistant Mycobacterium tuberculosis, the FDA said in briefing documents released ahead of an advisory committee.

Published
28 November 2012
From
MedPage Today
Paper Test Could Make Drug Treatment Safer

Researchers looking to make tuberculosis (TB) and HIV treatment safer have developed a paper-based test for drug-induced liver damage.

Published
19 November 2012
From
Asian Scientist Magazine
Scientists to study the role genes play in treating TB

The University of Liverpool has been awarded funding to determine whether differences in our genes determine how patients respond to drugs used to treat Tuberculosis in Sub-Saharan Africa.

Published
26 October 2012
From
Eurekalert Inf Dis
Structure discovered for promising tuberculosis drug target

Researchers at Johns Hopkins have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. The bonds make the bacteria resistant to currently available drug therapies, contributing to the alarming rise of these super-bacteria throughout the world.

Published
26 October 2012
From
Eurekalert Inf Dis
Risk of recurrence of active TB is high for people with HIV

People living with HIV who have a history of active tuberculosis (TB) have a significant risk of the recurrence of the disease, investigators report in the online

Published
22 October 2012
By
Michael Carter
20 million lives saved through TB care and control

An estimated 20 million people are alive today as a direct result of tuberculosis (TB) care and control, according to the WHO Global tuberculosis report 2012.

Published
17 October 2012
From
WHO
Curing TB in Europe is more about politics than science

Despite being considered as a disease of the past, tuberculosis (TB) kills seven people in Europe every hour and, worryingly, rates of multi drug resistant TB (MDR-TB) in the region are the highest in the world. With 81,000 MDR-TB cases in 2010 alone, the European region accounts for nearly 20 % of the global burden.

Published
11 October 2012
From
BMJ blogs
Launch of the Good Participatory Practice Guidelines for TB Drug Trials

The Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens initiative launches guidelines that will facilitate the involvement of communities and participants in the conduct of TB drug trials.

Published
04 October 2012
From
Critical Path to TB Drug Regimens

Filter by country